Skip to main content

Poulton Jeffrey V.'s Form 4 filing

Alnylam Pharmaceuticals, Inc. (ALNY) · filed Mar 4, 2026

Accession no.
0001735276-26-000053
Filed
Mar 4, 2026
Trade date
Mar 2, 2026
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 11 non-derivative transactions and 1 derivative transaction. Open-market sales total $722.8K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Poulton Jeffrey V.CIK 0001782962Officer (EVP, Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 2, 2026Common StockAGrant or awardAcquired+4,769$0.00$066,479Direct
Mar 2, 2026Common StockSSaleDisposed−65$323.62F3−$21,035.366,414Direct
Mar 2, 2026Common StockSSaleDisposed−124$324.65F4−$40,256.666,290Direct
Mar 2, 2026Common StockSSaleDisposed−356$325.63F5−$115,924.2865,934Direct
Mar 2, 2026Common StockSSaleDisposed−541$326.81F6−$176,804.2165,393Direct
Mar 2, 2026Common StockSSaleDisposed−454$327.67F7−$148,762.1864,939Direct
Mar 2, 2026Common StockSSaleDisposed−138$328.71F8−$45,361.9864,801Direct
Mar 2, 2026Common StockSSaleDisposed−234$329.71F9−$77,152.1464,567Direct
Mar 2, 2026Common StockSSaleDisposed−112$330.85F10−$37,055.264,455Direct
Mar 2, 2026Common StockSSaleDisposed−129$331.93F11−$42,818.9764,326Direct
Mar 2, 2026Common StockSSaleDisposed−53$332.64F12−$17,629.9264,273Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 2, 2026Common StockAGrant or awardAcquired+10,480$0.00$010,480Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $323.16 to $324.15. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F4

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $324.20 to $325.20. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F5

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $325.21 to $326.21. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F6

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $326.23 to $327.23. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F7

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $327.24 to $328.24. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F8

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $328.28 to $329.26. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F9

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $329.29 to $330.29. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F10

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $330.30 to $331.30. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F11

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $331.32 to $332.31. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

F12

The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $332.34 to $332.24. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)